Effect of zinc sulphate on menstrual cramps

Phase 2/3

Recruiting

Conditions: Primary dysmenorrhea,

Registration Number: CTRI/2018/06/014498

Lead Sponsor: Dr Ravali Ch

Brief Summary: Patients presenting to the OPD of Kasturba Hospital, Manipal with primary dysmenorrhea are included in the study.Written and informed consent will be taken from the participants for inclusion in the study. Alternate Patients will be prescribed zinc sulphate + mefenamic acid and mefenamic acid alone. Pain severity and duration will be compared between these two groups. Pain severity, by visual analogue scale, and pain duration are measured over 3

cycles. Mean pain duration and severity are calculated for the participants and compared to know the significance.

Detailed Description: Not available

Recruitment & Eligibility

Status: Open to Recruitment

Sex: Female

Target Recruitment: 52

Inclusion Criteria

Regular menstrual cycles (every 28 +/- 7 days) and with a history of primary dysmenorrhea for at least one day per month.

Exclusion Criteria

Evidence of gynecological disease (such as endometriosis, adenomyosis), significant medical history, women on antibiotics such as Quinolones, tetracyclineâ€™s and on thiazides, Penicillamine are excluded from the study.

Study & Design

Study Type: Observational

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
decrease in pain severity and duration	3 months

Secondary Outcome Measures

Name	Time	Method
Quality of life	3 months

Trial Locations

Locations (1): Kasturba hospital
🇮🇳
Udupi, KARNATAKA, India
Kasturba hospital
🇮🇳Udupi, KARNATAKA, India
Dr Ravali Ch
Principal investigator
8008019111
ravali.rau90@gmail.com